- Home
- SNYR vs DXR Comparison
SNYR vs DXR Comparison
Compare SNYR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNYR
- DXR
- Stock Information
- Founded
- SNYR 2010
- DXR 1970
- Country
- SNYR United States
- DXR United States
- Employees
- SNYR N/A
- DXR N/A
- Industry
- SNYR
- DXR Medical/Dental Instruments
- Sector
- SNYR
- DXR Health Care
- Exchange
- SNYR NYSE
- DXR Nasdaq
- Market Cap
- SNYR 16.6M
- DXR 36.4M
- IPO Year
- SNYR N/A
- DXR N/A
- Fundamental
- Price
- SNYR $3.16
- DXR $9.29
- Analyst Decision
- SNYR Strong Buy
- DXR Strong Buy
- Analyst Count
- SNYR 1
- DXR 1
- Target Price
- SNYR $10.00
- DXR $25.00
- AVG Volume (30 Days)
- SNYR 107.6K
- DXR 5.7K
- Earning Date
- SNYR 08-24-2025
- DXR 01-01-0001
- Dividend Yield
- SNYR N/A
- DXR N/A
- EPS Growth
- SNYR N/A
- DXR 86.16
- EPS
- SNYR 0.30
- DXR 0.11
- Revenue
- SNYR $33,592,914.00
- DXR $119,714.00
- Revenue This Year
- SNYR $37.83
- DXR N/A
- Revenue Next Year
- SNYR $18.39
- DXR N/A
- P/E Ratio
- SNYR $10.29
- DXR $87.40
- Revenue Growth
- SNYR N/A
- DXR N/A
- 52 Week Low
- SNYR $0.36
- DXR $6.55
- 52 Week High
- SNYR $10.00
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- SNYR N/A
- DXR 52.22
- Support Level
- SNYR N/A
- DXR $8.75
- Resistance Level
- SNYR N/A
- DXR $9.90
- Average True Range (ATR)
- SNYR 0.00
- DXR 0.56
- MACD
- SNYR 0.00
- DXR -0.07
- Stochastic Oscillator
- SNYR 0.00
- DXR 50.00
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.